These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8759906)

  • 21. Modeling the action of factor VIIa in dilutional coagulopathy.
    Monroe DM
    Thromb Res; 2008; 122 Suppl 1():S7-S10. PubMed ID: 18691504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
    Rao LV; Rapaport SI
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6687-91. PubMed ID: 3261869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F; Kelly CR; Ruf W; Edgington TS
    Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery.
    Falanga A; Ofosu FA; Cortelazzo S; Delaini F; Consonni R; Caccia R; Longatti S; Maran D; Rodeghiero F; Pogliani E
    Br J Haematol; 1993 Dec; 85(4):745-50. PubMed ID: 7918039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.
    Jerkeman A; Astermark J; Hedner U; Lethagen S; Olsson CG; Berntorp E
    Thromb Res; 2000 Jun; 98(6):467-71. PubMed ID: 10899345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III.
    Walker FJ; Esmon CT
    J Biol Chem; 1979 Jul; 254(13):5618-22. PubMed ID: 447671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postprandial triglycerides and blood coagulation.
    Silveira A
    Exp Clin Endocrinol Diabetes; 2001; 109(4):S527-32. PubMed ID: 11453040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sera on thrombin activation rate constants: a one-stage assay for the extrinsic system.
    Baughman DJ; Lytwyn A
    Ann N Y Acad Sci; 1981; 370():822-35. PubMed ID: 6168232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
    Morrissey JH
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of factor Xa-antithrombin III in plasma: relationship to prothrombin activation in vivo.
    Gouin-Thibault I; Dewar L; Kulczycky M; Sternbach M; Ofosu FA
    Br J Haematol; 1995 Jul; 90(3):669-80. PubMed ID: 7647008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of clotting factors in prothrombin complex concentrates as demonstrated by clotting assays for factors IXa and Xa.
    Elödi S; Váradi K
    Thromb Res; 1978 May; 12(5):797-807. PubMed ID: 675589
    [No Abstract]   [Full Text] [Related]  

  • 39. Extrinsic activation of human coagulation factors IX and X on the endothelial surface.
    Bom VJ; van Hinsbergh VW; Reinalda-Poot HH; Mohanlal RW; Bertina RM
    Thromb Haemost; 1991 Sep; 66(3):283-91. PubMed ID: 1745998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human ovarian follicular fluid has functional systems for the generation and modulation of thrombin.
    Gentry PA; Plante L; Schroeder MO; LaMarre J; Young JE; Dodds WG
    Fertil Steril; 2000 Apr; 73(4):848-54. PubMed ID: 10731552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.